X

XVIVO Perfusion AB

72 employees

XVIVO Perfusion develops optimized solutions for organ, tissue, and cell preservation in connection with transplantation.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Lung preservation
Machine perfusion
Research
Ex-vivo lung perfusion
Heart preservation
Organ preservation
Research collaboration
EVLP
Medical Device
Lung transplantation
Organ perfusion
Transplantation
Medical
EVOP

Date founded

1998

Funding rounds raised

Total raised

$63K

from 1 investors over 1 rounds

X

XVIVO Perfusion AB raised $63K on November 1, 2014

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ